BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 17658405)

  • 1. Flow cytometric assessment of T-cell chronic lymphoproliferative disorders.
    Cady FM; Morice WG
    Clin Lab Med; 2007 Sep; 27(3):513-32, vi. PubMed ID: 17658405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A practical approach to the flow cytometric detection and diagnosis of T-cell lymphoproliferative disorders.
    Meyerson HJ
    Lab Hematol; 2010 Sep; 16(3):32-52. PubMed ID: 20858587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric assessment of TCR-Vbeta expression in the evaluation of peripheral blood involvement by T-cell lymphoproliferative disorders: a comparison with conventional T-cell immunophenotyping and molecular genetic techniques.
    Morice WG; Kimlinger T; Katzmann JA; Lust JA; Heimgartner PJ; Halling KC; Hanson CA
    Am J Clin Pathol; 2004 Mar; 121(3):373-83. PubMed ID: 15023042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordant immunophenotype of chronic B-cell lymphoproliferative disorders in simultaneous specimens from bone marrow and peripheral sites.
    Liu YC; Cleveland RP; Madelaire C; Hines JD
    Arch Pathol Lab Med; 1995 Jan; 119(1):53-8. PubMed ID: 7802554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotypic patterns in precursor T-cell neoplasm.
    Gupta R; Naseem S; Kashyap R; Nityanand S
    Indian J Pathol Microbiol; 2007 Jan; 50(1):75-7. PubMed ID: 17474267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometry: an overview.
    Villas BH
    Cell Vis; 1998; 5(1):56-61. PubMed ID: 9660728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid and simple immunophenotypic characterization of lymphocytes using a new test.
    Bellido M; Rubiol E; Ubeda J; Estivill C; López O; Manteiga R; Nomdedéu JF
    Haematologica; 1998 Aug; 83(8):681-5. PubMed ID: 9793249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric immunophenotyping in posttransplant lymphoproliferative disorders.
    Dunphy CH; Gardner LJ; Grosso LE; Evans HL
    Am J Clin Pathol; 2002 Jan; 117(1):24-8. PubMed ID: 11789726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric analysis of lymphomas and lymphoproliferative disorders.
    Stetler-Stevenson M; Braylan RC
    Semin Hematol; 2001 Apr; 38(2):111-23. PubMed ID: 11309693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric analysis of T cell subsets in paired samples of cerebrospinal fluid and peripheral blood from patients with neurological and psychiatric disorders.
    Maxeiner HG; Rojewski MT; Schmitt A; Tumani H; Bechter K; Schmitt M
    Brain Behav Immun; 2009 Jan; 23(1):134-42. PubMed ID: 18771722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CD45 isoform B220 identifies select subsets of human B cells and B-cell lymphoproliferative disorders.
    Rodig SJ; Shahsafaei A; Li B; Dorfman DM
    Hum Pathol; 2005 Jan; 36(1):51-7. PubMed ID: 15712182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry.
    Gelain ME; Mazzilli M; Riondato F; Marconato L; Comazzi S
    Vet Immunol Immunopathol; 2008 Feb; 121(3-4):179-88. PubMed ID: 17981339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis.
    Rothe G; Schmitz G
    Leukemia; 1996 May; 10(5):877-95. PubMed ID: 8656686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New developments in flow cytometric analyses of lymphocyte markers.
    Kipps TJ; Meisenholder G; Robbins BA
    Clin Lab Med; 1992 Jun; 12(2):237-75. PubMed ID: 1611820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotyping of selected hematologic disorders--focus on lymphoproliferative disorders with more than one malignant cell population.
    Porwit A
    Int J Lab Hematol; 2013 Jun; 35(3):275-82. PubMed ID: 23590655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotyping of lymphoproliferative disorders: state of the art.
    Gudgin EJ; Erber WN
    Pathology; 2005 Dec; 37(6):457-78. PubMed ID: 16373227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracking the follicular lymphoma cells in flow cytometry: characterisation of a new useful antibody combination.
    Detry G; Drénou B; Ferrant A; Theate I; Michaux L; Scheiff JM; Latinne D; Leveugle P; Mazzon AM; Deneys V
    Eur J Haematol; 2004 Nov; 73(5):325-31. PubMed ID: 15458511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of surface and cytoplasmic immunoglobulin light/heavy chains by flow cytometry using a lysed-whole-blood technique: Implications for the differential diagnosis of B-cell malignancies.
    Babusíková O; Stevulová L
    Neoplasma; 2004; 51(6):422-30. PubMed ID: 15640950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic usefulness of aberrant CD22 expression in differentiating neoplastic cells of B-Cell chronic lymphoproliferative disorders from admixed benign B cells in four-color multiparameter flow cytometry.
    Huang J; Fan G; Zhong Y; Gatter K; Braziel R; Gross G; Bakke A
    Am J Clin Pathol; 2005 Jun; 123(6):826-32. PubMed ID: 15899772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of phenotypic markers used in flow cytometric analysis of MGUS and MM, and applicability of flow cytometry in other plasma cell disorders.
    Raja KR; Kovarova L; Hajek R
    Br J Haematol; 2010 May; 149(3):334-51. PubMed ID: 20201947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.